Show
Sort by
-
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials
-
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study
-
Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)
-
- Journal Article
- A1
- open access
Mepolizumab for chronic rhinosinusitis with nasal polyps : treatment efficacy by comorbidity and blood eosinophil count
-
Efficacy of dupilumab in chronic rhinosinusitis with nasal polyps and comorbid asthma by baseline biomarkers of type 2 inflammation: SINUS-24 and SINUS-52 phase 3 trials
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
-
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial
-
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
-
Liberty asthma traverse dupilumab shows sustained efficacy and improvements in asthma control and health-related quality of life (HRQOL) in patients with moderate-to-severe asthma